Cargando…
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death
Facioscapulohumeral muscular dystrophy (FSHD) results from mutations causing overexpression of the transcription factor, DUX4, which interacts with the histone acetyltransferases, EP300 and CBP. We describe the activity of a new spirocyclic EP300/CBP inhibitor, iP300w, which inhibits the cytotoxicit...
Autores principales: | Bosnakovski, Darko, da Silva, Meiricris T., Sunny, Sithara T., Ener, Elizabeth T., Toso, Erik A., Yuan, Ce, Cui, Ziyou, Walters, Michael A., Jadhav, Ajit, Kyba, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739093/ https://www.ncbi.nlm.nih.gov/pubmed/31535023 http://dx.doi.org/10.1126/sciadv.aaw7781 |
Ejemplares similares
-
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
por: Bosnakovski, Darko, et al.
Publicado: (2021) -
Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression
por: Bosnakovski, Darko, et al.
Publicado: (2018) -
High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity
por: Bosnakovski, Darko, et al.
Publicado: (2014) -
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
por: Choi, Si Ho, et al.
Publicado: (2016) -
Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein
por: Bosnakovski, Darko, et al.
Publicado: (2023)